Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine

Neuroscience

Volumn 98, Issue 2, 2000, Pages 287-293

  Flores, C ^a   Stewart, J ^a  

^a and Applied Physiology   (Canada)

Author keywords

Astrocytes; bFGF; Dopamine; FGF 2; Neurotrophic factors; Stimulant drug

Indexed keywords

AMPHETAMINE; BASIC FIBROBLAST GROWTH FACTOR; NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG EXPOSURE; GENE EXPRESSION; IMMUNOREACTIVITY; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ASTROCYTES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; MALE; NUCLEUS ACCUMBENS; OCCIPITAL LOBE; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0034039912     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00115-9     Document Type: Article

References (63)

1. Beitner-Johnson D., Guitart X., Nestler E.J. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61:1993;1766-1773.
2. Bjijou Y., Stinus L., Le Moal M., Cador M. Evidence for a selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J. Pharmac. exp. Ther. 277:1996;1177-1187.
3. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience. 65:1995;385-395.
4. Camp D.M., DeJonghe D.K., Robinson T.E. Time-dependent effects of repeated amphetamine treatment on norepinephrine in the hypothalamus and hippocampus assessed with in vivo microdialysis. Neuropsychopharmacology. 17:1997;130-140.
5. Carlezon W.A., Boundy V.A., Haile C.N., Lane S.B., Kalb R.G., Neve R.L., Nestler E.J. Sensitization to morphine induced by viral-mediated gene transfer. Science. 277:1997;812-814.
6. Castner S.A., Goldman-Rakic P.S. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology. 20:1999;10-28.
7. Chadi G., Cao Y., Pettersson R.F., Fuxe K. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons. Neuroscience. 61:1994;891-910.
8. Ellinwood E. H. (1972) Amphetamine psychosis: individuals, settings, and sequences. In Current Concepts on Amphetamine Abuse (eds Ellinwood E. H. and Cohen S.). US Govt Printing Office, Washington, DC.
9. Fagan A.M., Suhr S.T., Lucidi-Phillipi C.A., Peterson D.A., Holtzman D.M., Gage F.H. Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus. J. Neurosci. 17:1997;2499-2511.
10. Fallon J. H. and Loughlin S. E. (1987) Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. In Cerebral Cortex (eds Jones E. and Peters A.). Plenum, New York.
11. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. comp. Neurol. 180:1978;545-580.
12. Ferhat L., Represa A., Zouaoui-Aggoun D., Ferhat W., Ben-Ari Y., Khrestchatisky M. FGF-2 induces nerve growth factor expression in cultured rat hippocampal neurons. Eur. J. Neurosci. 9:1997;1282-1289.
13. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
14. Flores C., Rodaros D., Stewart J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J. Neurosci. 18:1998;9547-9555.
15. Flores C., Salmaso N., Cain S., Rodaros D., Stewart J. Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex. J. Neurosci. 19:1999;8665-8673.
16. Flores C., Samaha A.-N., Stewart J. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine. J. Neurosci. 20RC55:2000;1-5.
17. Flott-Rahmel B., Gerdes W., Pechan P.A., Brysch W., Schlingensiepen K.H., Seifert W. bFGF induces its own gene expression in astrocytic and hippocampal cell cultures. NeuroReport. 3:1992;1077-1080.
18. Fornstedt B., Pileblad E., Carlsson A. In vivo autoxidation of dopamine in guinea pig striatum increases with age. J. Neurochem. 55:1990;655-659.
19. Gómez-Pinilla F., Lee J.W.-K., Cotman C.W. Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J. Neurosci. 12:1992;345-355.
20. Hou J.-G.G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69:1997;76-83.
21. Hsu S.M., Raine L., Fanger H. The use of anti-avidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am. J. clin. Pathol. 75:1981;816-821.
22. Kalivas P.W., Duffy P. D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 15:1995;5379-5388.
23. Kalivas P.W., Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem. 70:1998;1497-1502.
24. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
25. Kalivas P.W., Weber B. Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine and cocaine. J. Pharmac. exp. Ther. 245:1988;1095-1102.
26. Kawamata T., Dietrich W.D., Schallert T., Gotts J.E., Cocke R.R., Benowitz L.I., Finklestein S.P. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc. natn. Acad. Sci. U.S.A. 94:1997;8179-8184.
27. Kolta M.G., Shreve P., De Souza V., Uretsky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
28. Kramer J., Fischman V., Littlefield D. Amphetamine abuse. J. Am. med. Assoc. 201:1967;305-309.
29. Krieglstein K., Reuss B., Maysinger D., Unsicker K. Transforming growth factor-beta mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons. Eur. J. Neurosci. 10:1998;2746-2750.
30. Kuczenski R. and Segal D. S. (1994) Neurochemistry of amphetamine. In Amphetamine and its Analogs: Psychopharmacology, Toxicology, and Abuse (eds Cho A. K. and Segal D. S.). Academic, San Diego, CA.
31. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology. 98:1989;357-362.
32. Lorrain D., Arnold G., Vezina P. Previous exposure to amphetamine increases incentive to obtain the drug: long lasting effects revealed by the progressive ratio schedule. Behav. Brain Res. 107:2000;9-19.
33. Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H., Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. natn. Acad. Sci. U.S.A. 86:1989;9911-9915.
34. Mendrek A., Blaha C.D., Phillips A.G. Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology. 135:1998;416-422.
35. Moffett J., Kratz E., Florkiewicz R., Stachowiak M.K. Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells. Proc. natn. Acad. Sci. U.S.A. 93:1996;2470-2475.
36. Moffett J., Kratz E., Myers J., Stachowiak E.K., Florkiewicz R.Z., Stachowiak M.K. Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity. Molec. Biol. Cell. 9:1998;2269-2285.
37. Nieto-Sampedro M. and Cotman C. W. (1985) Growth factor induction and temporal order in central nervous system repair. In Synaptic Plasticity (ed. Cotman C.). Guilford, New York.
38. Paulson P.E., Robinson T.E. Sensitization to systemic amphetamine produces an enhanced locomotor response to subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology. 104:1991;140-141.
39. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
40. Paulson P.E., Robinson T.E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 19:1995;56-65.
41. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic, New York.
42. Pechan P.A., Chowdhury K., Gerdes W., Seifert W. Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture. Neurosci. Lett. 153:1993;111-114.
43. Pechan P.A., Chowdhury K., Seifert W. Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. NeuroReport. 3:1992;469-472.
44. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
45. Ramirez J.J., Finklestein S.P., Keller J., Abrams W., George M.N., Parakh T. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. NeuroReport. 10:1999;1201-1204.
46. Reid M.S, Hsu K., Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 27:1997;95-105.
47. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:1997;8491-8497.
48. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1999;1598-1604.
49. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 396:1986;157-198.
50. Rowntree S., Kolb B. Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats. Eur. J. Neurosci. 9:1997;2432-2441.
51. Sklair-Tavron L., Shi W.-X., Lane S.B., Harris H.W., Bunney B.S., Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. natn. Acad. Sci. U.S.A. 93:1996;11202-11207.
52. Tong Z.-Y., Overton P.G., Clark D. Chronic administration of (+)-amphetamine alters the reactivity of midbrain neurons to prefrontal cortex stimulation in the rat. Brain Res. 674:1995;63-74.
53. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605:1993;332-337.
54. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16:1996;2411-2420.
55. Vezina P., Pierre P., Lorrain D. The effects of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug. Psychopharmacology. 147:1999;125-134.
56. White F.J., Hu X.T., Zhang X.F., Wolf M.E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmac. exp. Ther. 273:1995;445-454.
57. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
58. Wolf M.E., Xue C.J. Amphetamine and D1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: modification by repeated amphetamine administration. J. Neurochem. 70:1998;198-209.
59. Wolf M.E., Xue C.J. Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex. J. Neurochem. 73:1999;1529-1538.
60. Wolf M.E., White F.J., Nassar R.N., Brooderson R.J., Khansa M.R. Differential development of autoreceptor supersensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmac. exp. Ther. 264:1993;249-255.
61. Xue C.J., Ng J.P., Li Y., Wolf M.E. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67:1996;352-363.
62. Zhou D., Difiglia M. Basic fibroblast growth factor enhances the growth of postnatal neostriatal GABAergic neurons in vitro. Expl Neurol. 122:1993;171-188.
63. Zilles K. The Cortex of the Rat: a Stereotaxic Atlas. 1985;Springer-Verlag, New York.